Mustiatsé L Z, Korchmaru I F
Ter Arkh. 1986;58(6):110-2.
The authors present the results of the COP therapy of 85 patients with generalized lymphoblastic and immunoblastic lymphosarcomas. Antirelapse therapy with cyclophosphamide and reinduction courses according to the COP scheme and COP reinduction courses only increase the period of remission. A necessity of antirelapse therapy after achieving a complete remission is substantiated.
作者介绍了85例全身性淋巴细胞性和免疫母细胞性淋巴肉瘤患者接受COP疗法的结果。采用环磷酰胺进行抗复发治疗以及按照COP方案进行再诱导疗程和仅采用COP再诱导疗程,均能延长缓解期。证实了在完全缓解后进行抗复发治疗的必要性。